Blog - INTERNET MÉDICA

Nefrologia: Perguntas & Respostas (Nephrology: Questions & Answers)

Por Paulo Leite 09/07/2021

■ Qual o papel dos biomarcadores de lesão renal na nefropatia induzida por contraste

P P M Spineti

Arq Bras Cardiol 2021, vol 116 (6)

https://www.scielo.br/j/abc/a/NXVPS4VfkpmzZQj85WNpvmn/?lang=pt

■ Risco de insuficiência renal aguda pós-contraste em tomografia computadoriza: Estamos atentos à função renal

B C Juchem, F B de Sousa, C Karohl et al

Clinical & Biomedical Research 2019, vol 39 (1)

https://seer.ufrgs.br/hcpa/article/view/90598/pdf

■ Cognitive performance in dialysis patients – ¨when is the right time to test?

Hristos Karakizlis, Stefanie Thiele, Brandon Greene, Joachim Hoyer

BMC Nephrol. 2021; 22: 205

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171038/

■ Management of patient with a failed kidney transplant: what should we do?

Marco Fiorentino, Pasquale Gallo, Marica Giliberti, Vincenza Colucci et al

Clin Kidney J. 2021 Jan; 14(1): 98–106

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857798/

■ Routine immunohistochemistry study for polyomavirus BK nephropathy in transplanted kidney biopsies, is it recommended?

Fatemeh Nili, Maliheh Mohammadhoseini, Seyed Mohammadreza Khatami et al

BMC Nephrol. 2021; 22: 226

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212535/

■ Personalizing the kidney transplant decision: Who doesn´t benefit from a kidney transplant?

Deirdre Sawinski, David P. Foley

Clin J Am Soc Nephrol. 2020 Feb 7; 15(2): 279–281

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015096/

■ Assessment of patients referred to urgent start peritoneal dialysis: when does the nurse contraindicate?

Helen Caroline Ferreira, Fabiana Baggio Nerbass, Viviane Calice-Silva

J Bras Nefrol. 2021 Jan-Mar; 43(1): 47–51

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061952/

■ Does cystatin C have a role as metabolic surrogate in peritoneal dialysis beyond its association with residual renal function?

Carla Leal Moreira, Liliana Cunha, Sofia Correia et al

J Bras Nefrol. 2020 Jan-Mar; 42(1): 31–37

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213933/

■ Tyrosine kinase inhibitor-induced hypertension – marker of anti-tumour treatment efficacy or cardiovascular risk factor?

Anastasia G. Ptinopoulou, Ben Sprangers

Clin Kidney J. 2021 Jan; 14(1): 14–17

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857807/

■ Aspiration-sclerotherapy versus laparoscopic de-roofing in the treatment of renal cysts: which is better?

Xueling Zhang, Dehong Cao, Peizhen Han et al

BMC Nephrol. 2020; 21: 193

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245882/

■ Evidence in chronic kidney disease – mineral and bone disorder guidelines: is it time to treat or time to wait?

Jordi Bover, Pablo Ureña-Torres, Silvia Mateu et al

Clin Kidney J. 2020 Aug; 13(4): 513–521

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467585/

■ Renal function and delirium in older fracture patients: different information from different formulas?

E Mossello, G Rivasi, V Tortù et al

European Journal of Internal Medicine 2020, vol 71: p70-p75

https://www.ejinme.com/article/S0953-6205(19)30361-9/fulltext

■ Do virtual renal clinics improve acess to kidney care? A preliminary impact evaluation of a virtual clinic in East London

A. Hull, V. Rajabzadeh, N. Thomas, S. Hoong et al

BMC Nephrol. 2020; 21: 1

https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-020-1682-6

■ Does chronic kidney disease predict stroke risk independent of blood pressure? A systematic review and meta-regression

Dearbhla M. Kelly, Peter M. Rothwell

Stroke. 2019 Nov; 50(11): 3085–3092.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824504/

■ Could IL-17A be a novel therapeutic target in diabetic nephropathy?

Carolina Lavoz, Sandra Rayego-Mateos, Macarena Orejudo et al

J Clin Med. 2020 Jan; 9(1): 272

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019373/

■ Is uric acid elevation a random finding or a causative agent of diabetic nephropathy?

M Z Kock, G Aktas, T T Duman et al

Rev Assoc Med Bras 2019, vol 65 (9)

https://www.scielo.br/j/ramb/a/kywbqX9NV45nDBtLsnVqpPR/abstract/?lang=en

■ Does chronic kidney disease result in high risk of atrial fibrillation?

Dapeng Zhang, Yibin Feng, Feona Chung-Yin Leung et al

Front Cardiovasc Med. 2019; 6: 82

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595216/

■ Do routine hospital data accurately record comorbidity in advanced kidney disease populations? A record linkage cohort study

Ailish Nimmo, Retha Steenkamp, Rommel Ravanan, Dominic Taylor

BMC Nephrol. 2021; 22: 95.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968235/

■ Significance of kidney biopsy dominant tubulointerstitial kidney disease – UMOD: is kidney biopsy truly nonspecific?

Tamehito Onoe, Satoshi Hara, Kazunori Yamada et al

BMC Nephrol. 2021; 22: 1

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784305/

■ Sugar of fat? Renal tubular metabolism reviewed in health and disease

Leslie S. Gewin

Nutrients. 2021 May; 13(5): 1580

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151053/

■ Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Consultório: Rua Padre Rolim 815/sala 601 – Belo Horizonte/MG/Brasil

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

Blog Internet Médica – www.internetmedica.com.br

Data: julho 2021

Deficiência de Vitamina C: Casos Clínicos (Scurvy: Case Report)

Por Paulo Leite 07/07/2021

– Indivíduos que vivem sozinhos e têm histórico de abuso de substâncias, dieta restritiva ou doença mental têm muito mais probabilidade de desenvolver escorbuto. Nos Estados Unidos e em outros países desenvolvidos, é frequentemente assumido que a incidência de deficiência de vitamina C ou escorbuto é insignificante devido ao amplo acesso a alimentos fortificados e vitaminas. As manifestações iniciais comuns de escorbuto incluem anemia, dor óssea, fácil hematoma, petéquias, doença gengival, hemorragias perifoliculares nas extremidades inferiores e alterações do humor. Uma manifestação rara é a hipertensão pulmonar. O escorbuto está associado a má dentição e diáteses hemorrágicas.

■ Scurvy: a case report and literature review

J M Thomas, K M Burtson

Cureus 2021, vol 13 (4): e14312

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099386/

■ Pediatric scurvy MRI appearance

A Ganske, A B Kolbe, K Thomas, N Hull

Radiol Case Rep 2021, vol 16 (5): 1148-1152

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960501/

■ Severe pulmonary hypertension in a patient wity scurvy: Can a vitamin reverse it?

Vandan Shah, Ruchit N. Shah, Lauren Greene, Lauren M. DiMarino

Case Rep Med. 2021; 2021: 5519937

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024066/